title: Modification of c and n sources for enhanced production of cyclosporin 'a' by Aspergillus Terreus.
abstract: Most of the studies regarding cyclosporin 'A' production through fungi concentrate around Tolypocladium inflatum. This is mainly due to lower reported production of this drug in other fungi. The present study was therefore conducted to explore indigenous isolates of Aspergillus terreus for synthesis of this drug and defining a production medium for obtaining high yield of cyclosporin 'A'. For this purpose carbon and nitrogen sources were optimized for the selected best strain of A. terreus. Overall results depicted that the best cyclosporin 'A' yield from selected Aspergillus terreus (FCBP58) could be obtained by using production medium containing glucose 10% as carbon source and peptone 0.5% as nitrogen source. This modification in production medium enhanced drug synthesis by selected fungi significantly. The production capabilities when compared with biomass of fungi there was found no relationship between the two confirming that the medium modification increased overall drug synthesis powers of the fungi.
authors.affiliation: Institute of Mycology & Plant Pathology, University of the Punjab , Lahore , Pakistan.
authors.forename: Sundas
authors.initials: S
authors.lastname: Tanseer
authors.forename: Tehmina
authors.initials: T
authors.lastname: Anjum
keywords: Aspergillus terreus; carbon; cyclosporin ‘A’; nitrogen
references.citation: Immunology. 1977 Jun;32(6):1017-25
references.pmid: 328380
references.citation: J Biol Chem. 1987 Dec 25;262(36):17258-9
references.pmid: 3693349
references.citation: Indian J Med Res. 2006 Apr;123(4):525-30
references.pmid: 16783043
references.citation: Biotechnol Prog. 1993 Jan-Feb;9(1):54-63
references.pmid: 7763411
references.citation: Biotechnol Prog. 1997 Sep-Oct;13(5):546-50
references.pmid: 9376111
references.citation: Eukaryot Cell. 2004 Apr;3(2):527-35
references.pmid: 15075281
references.citation: Prog Allergy. 1986;38:9-18
references.pmid: 3523497
references.citation: Antimicrob Agents Chemother. 1990 Jan;34(1):121-7
references.pmid: 2327746
references.citation: J Gen Appl Microbiol. 2005 Jun;51(3):143-9
references.pmid: 16107751
references.citation: J Antibiot (Tokyo). 1989 Aug;42(8):1283-9
references.pmid: 2759908
references.citation: J Microbiol Biotechnol. 2008 May;18(5):913-7
references.pmid: 18633291
references.citation: J Gen Appl Microbiol. 2003 Dec;49(6):321-8
references.pmid: 14747973
references.citation: J Biotechnol. 1993 Feb;27(3):283-94
references.pmid: 7763467
references.citation: Braz J Microbiol. 2008 Jul;39(3):561-8
references.pmid: 24031266
references.citation: Appl Microbiol Biotechnol. 1991 Jan;34(4):513-7
references.pmid: 1367231
references.citation: Mol Genet Genomics. 2001 Dec;266(4):527-36
references.pmid: 11810223